PF3D7_0501100

PF3D7_0501100 (PFE0055c) is an exported P. falciparum type II J-domain co-chaperone that is trafficked into the cytosol of the infected human erythrocyte, where it localizes to novel punctate, highly mobile, cholesterol-sensitive membrane-associated structures termed J-dots that are distinct from Maurer's clefts (PMID:20482550). Its export to the host cell cytosol was independently confirmed by a self-assembling split-GFP compartmentalization assay (PMID:23271009), and its predicted substrate-binding domain is both necessary and sufficient for J-dot targeting; this targeting operates in P. falciparum-infected but not P. berghei-infected erythrocytes, indicating a P. falciparum-specific mechanism (PMID:27063072). Functionally, recombinant PFE0055c acts as a co-chaperone by stimulating the basal ATPase activity of the exported malarial chaperone PfHsp70-x through its J domain, an interaction blocked by the J-domain inhibitor C86, while its isolated J domain promiscuously stimulates PfHsp70-x as well as human HSP70 and HSC70 in vitro (PMID:33236291, PMID:41618743). Within J-dots it associates with PfHsp70-x and the co-chaperone PFA0660w (PMID:34569022). Beyond this exported co-chaperone role and its partnership with PfHsp70-x, no direct client substrate of PF3D7_0501100 has been characterized in the available corpus.

1. 2010 Medium

   Establishing where an exported J-domain protein resides in the host cell was the first step in defining its role; PFE0055c was found in a previously unrecognized mobile, cholesterol-dependent compartment, defining the J-dot as a distinct trafficking structure.

   Evidence GFP/HA-Strep fusion expression with fluorescence and electron microscopy, BODIPY-ceramide staining, detergent fractionation and cholesterol depletion in P. falciparum-infected erythrocytes

   PMID:20482550

   Open questions at the time

   • The identity of the cholesterol-rich membrane binding partner was not determined
   • Direct evidence that J-dots traffic parasite proteins was not shown
2. 2012 Medium

   Because localization by fluorescence alone can be ambiguous, an orthogonal method was needed to confirm that PFE0055c is genuinely exported across the parasite membrane into the erythrocyte cytosol.

   Evidence Self-assembling split-GFP compartmentalization assay in transfected P. falciparum-infected erythrocytes

   PMID:23271009

   Open questions at the time

   • No functional consequence of export tested
   • Single orthogonal method
3. 2016 Medium

   To understand how PFE0055c reaches J-dots, domain dissection identified the substrate-binding domain as necessary and sufficient for targeting, and cross-species comparison established that this targeting is P. falciparum-specific.

   Evidence GFP chimeras with domain deletions/truncations expressed in P. falciparum and P. berghei-infected erythrocytes with fluorescence microscopy

   PMID:27063072

   Open questions at the time

   • The molecular receptor recognizing the substrate-binding domain at J-dots is unidentified
   • Basis for P. falciparum specificity not defined
4. 2020 High

   Assigning a biochemical co-chaperone function required demonstrating a chaperone partner; reconstitution showed PFE0055c stimulates PfHsp70-x ATPase activity through its J domain with preference for the malarial over the human chaperone.

   Evidence In vitro ATPase assays with recombinant PFE0055c and PfHsp70-x plus J-domain inhibitor (C86) and rhodacyanine inhibitor validation

   PMID:33236291

   Open questions at the time

   • No client/substrate protein handed off to PfHsp70-x was identified
   • Stoichiometry and structure of the co-chaperone–chaperone complex not determined
5. 2021 Low

   A review consolidated PFE0055c into the J-dot complex with PfHsp70-x and PFA0660w and raised its potential genetic essentiality, framing it as a candidate antimalarial target.

   Evidence Review summarizing prior localization findings and genetic essentiality data

   PMID:34569022

   Open questions at the time

   • Essentiality claim not backed by a primary experiment described in this paper
   • No new mechanistic data generated
6. 2023 Low

   To exploit the PfHsp70-x–PFE0055c partnership pharmacologically, computational screening predicted small molecules that either disrupt or stabilize the complex with preferential affinity for the malarial system.

   Evidence In silico molecular docking and molecular dynamics simulation against the PfHsp70-x–PFE0055c complex

   PMID:37621993

   Open questions at the time

   • Purely computational — no experimental binding or activity validation
   • No cellular efficacy tested
7. 2026 Medium

   To define the intrinsic selectivity of the PFE0055c J domain, isolated J-domain assays showed it can promiscuously stimulate malarial and human HSP70s, with differing magnitudes across pairings.

   Evidence In vitro ATPase stimulation assays using isolated recombinant J-domains and purified HSP70s

   PMID:41618743

   Open questions at the time

   • Full-length versus isolated-domain selectivity differences not reconciled
   • Single lab, single assay

• The physiological client proteins chaperoned by the PFE0055c–PfHsp70-x complex within J-dots, and the direct in vivo consequence of disrupting this partnership on virulence-protein trafficking, remain unresolved.
• No client substrate directly identified in the corpus
• No structure of the PFE0055c–PfHsp70-x complex
• In vivo essentiality not established by a described primary experiment